About Adalvo
Adalvo is a company based in San Gwann (Malta) founded in 2019 was acquired by EQT in July 2025. The company has 31 employees as of April 03, 2024. Adalvo offers products and services including Tacrolimus Ointment and Fidaxomicin. Adalvo operates in a competitive market with competitors including OPEN Health, Target RWE, Secura Bio, STATinMED Research and Abacus Medicine, among others.
- Headquarter San Gwann, Malta
- Employees 31 as on 03 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Adalvo India Private Limited
- Date of Incorporation 26 Aug, 2021
- Jurisdiction Bangalore, Karnataka, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Adalvo
Adalvo offers a comprehensive portfolio of products and services, including Tacrolimus Ointment and Fidaxomicin.
Ointment for treating specific skin conditions in patients.
Medication used for bacterial infection treatment in healthcare.
Funding Insights of Adalvo
Detailed funding history for Adalvo
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Adalvo
Adalvo has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include EQT, Aztiq and Innobic Asia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
EQT is recognized as a global investment organization focused on value creation.
|
Locked | Locked | Locked | |
|
Aztiq is focused on investments in pharmaceutical and biotechnology sectors.
|
Locked | Locked | Locked | |
|
Operates as a CDMO specializing in solid-based drug production.
|
Locked | Locked | Locked |
Investor details for Adalvo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Adalvo
Investment portfolio details for Adalvo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Adalvo
Detailed financials for Adalvo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adalvo Comparisons
Peer comparison for Adalvo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Adalvo
Adalvo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OPEN Health, Target RWE, Secura Bio, STATinMED Research and Abacus Medicine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of healthcare marketing services
|
|
| Locked | Locked | Locked |
Marketing services to the pharmaceutical industry are provided.
|
|
| Locked | Locked | Locked |
Consulting services for market access and health outcomes are provided.
|
|
| Locked | Locked | Locked |
Healthcare data analytics services provider
|
|
| Locked | Locked | Locked |
Consulting services for market access, health economics and outcomes research
|
|
| Locked | Locked | Locked |
Offers business insurance, employee benefits, and risk consulting services worldwide.
|
Detailed competitors of Adalvo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adalvo
Complete news archive for Adalvo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adalvo
Adalvo was founded in 2019.
Adalvo is headquartered in San Gwann, Malta.
As of Apr 03, 2024, the latest employee count at Adalvo is 31.
Annual revenue of Adalvo is $1.33M as on Mar 31, 2023.
Adalvo was established in 2019 and is headquartered in San Gwann, Malta. Services in marketing are delivered specifically to entities within the pharmaceutical sector. Operations center on supporting promotional and strategic needs for pharmaceutical clients. The companys domain, adalvo.com, facilitates these activities. Focus remains on the European pharmaceutical market, with tailored solutions for industry compliance and outreach.
Adalvo's top competitors include OPEN Health, Abacus Medicine and Target RWE.
Adalvo offers Tacrolimus Ointment and Fidaxomicin.
Adalvo has 3 investors. Key investors include EQT, Aztiq, and Innobic Asia.